c NSCLC patients with lymph node metastasis (N2–N3) had a lower Smad4 expression than patients with lymph node metastasis (N0–N1) (P = 0.010). The gene discussed is SMAD4; the disease is metastatic malignant neoplasm in the lymph nodes.